Cinctive Capital Management LP Buys 2,814 Shares of Tenet Healthcare Corporation $THC

Cinctive Capital Management LP raised its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 35.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,829 shares of the company’s stock after acquiring an additional 2,814 shares during the period. Cinctive Capital Management LP’s holdings in Tenet Healthcare were worth $2,199,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. William B. Walkup & Associates Inc. bought a new stake in Tenet Healthcare in the 3rd quarter valued at $32,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare during the 2nd quarter worth $35,000. Westside Investment Management Inc. lifted its holdings in shares of Tenet Healthcare by 100.0% during the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after buying an additional 96 shares in the last quarter. Trust Co. of Vermont bought a new stake in shares of Tenet Healthcare in the third quarter valued at about $41,000. Finally, Geneos Wealth Management Inc. grew its stake in shares of Tenet Healthcare by 50.9% in the second quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock valued at $46,000 after acquiring an additional 89 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on THC. Truist Financial boosted their price objective on shares of Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Wells Fargo & Company reiterated an “overweight” rating and issued a $265.00 price target on shares of Tenet Healthcare in a research report on Monday, February 16th. KeyCorp boosted their price target on Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Thursday, February 12th. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Finally, Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Sunday, March 1st. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $250.56.

Insider Activity at Tenet Healthcare

In related news, insider R. Scott Ramsey sold 8,017 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Thomas W. Arnst sold 8,000 shares of the business’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $238.85, for a total value of $1,910,800.00. Following the transaction, the executive vice president directly owned 12 shares of the company’s stock, valued at approximately $2,866.20. The trade was a 99.85% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 46,517 shares of company stock valued at $10,943,111 over the last ninety days. 0.81% of the stock is owned by corporate insiders.

Tenet Healthcare Stock Performance

NYSE THC opened at $219.58 on Tuesday. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $247.21. The firm has a market capitalization of $19.09 billion, a price-to-earnings ratio of 14.18, a P/E/G ratio of 1.10 and a beta of 1.39. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. The firm’s 50 day simple moving average is $213.71 and its 200 day simple moving average is $204.56.

Tenet Healthcare (NYSE:THC) last released its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. During the same period in the prior year, the company earned $3.44 earnings per share. The company’s quarterly revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.